RVLP
Price:
$0.0282
Market Cap:
$3.14M
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.[Read more]
Industry
Biotechnology
IPO Date
2018-10-19
Stock Exchange
NASDAQ
Ticker
RVLP
According to RVL Pharmaceuticals plc’s latest financial reports and current stock price. The company's current Enterprise Value is 42.13M. This represents a change of -69.29% compared to the average of 137.17M of the last 4 quarters.
The mean historical Enterprise Value of RVL Pharmaceuticals plc over the last ten years is 419.60M. The current 42.13M Enterprise Value has changed 904.04% with respect to the historical average. Over the past ten years (40 quarters), RVLP's Enterprise Value was at its highest in in the June 2018 quarter at 706.85M. The Enterprise Value was at its lowest in in the September 2017 quarter at 0.
Average
419.60M
Median
543.48M
Minimum
79.94M
Maximum
658.70M
Discovering the peaks and valleys of RVL Pharmaceuticals plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 42.00%
Maximum Annual Enterprise Value = 658.70M
Minimum Annual Increase = -77.64%
Minimum Annual Enterprise Value = 79.94M
Year | Enterprise Value | Change |
---|---|---|
2022 | 113.52M | 42.00% |
2021 | 79.94M | -77.64% |
2020 | 357.45M | -34.23% |
2019 | 543.48M | -0.99% |
2018 | 548.89M | -13.59% |
2017 | 635.23M | -3.56% |
The current Enterprise Value of RVL Pharmaceuticals plc (RVLP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
183.64M
5-year avg
328.66M
10-year avg
419.60M
RVL Pharmaceuticals plc’s Enterprise Value is less than Molecular Partners AG (0), greater than MediciNova, Inc. (-1929773.37), less than Anebulo Pharmaceuticals, Inc. (59.15M), greater than Champions Oncology, Inc. (41.53M), less than Cyteir Therapeutics, Inc. (62.59M), greater than Aerovate Therapeutics, Inc. (-20511738.00), greater than Adagene Inc. (24.46M), greater than Acrivon Therapeutics, Inc. Common Stock (40.66M), less than Rezolute, Inc. (208.47M), less than AN2 Therapeutics, Inc. (237.24M), greater than PMV Pharmaceuticals, Inc. (3.67M), greater than Eliem Therapeutics, Inc. (40.92M), less than HCW Biologics Inc. (272.53M), greater than Sensei Biotherapeutics, Inc. (35.48M), greater than NextCure, Inc. (8.47M), greater than Nuvation Bio Inc. (25.04M), less than Graphite Bio, Inc. (947.94M), greater than Merrimack Pharmaceuticals, Inc. (-15007658.00), greater than null (-10189682.00),
Company | Enterprise Value | Market cap |
---|---|---|
0 | $182.90M | |
-1929773.37 | $103.00M | |
59.15M | $46.68M | |
41.53M | $57.77M | |
62.59M | $108.71M | |
-20511738.00 | $54.85M | |
24.46M | $115.55M | |
40.66M | $250.26M | |
208.47M | $240.80M | |
237.24M | $30.44M | |
3.67M | $77.28M | |
40.92M | $495.57M | |
272.53M | $26.62M | |
35.48M | $15.32M | |
8.47M | $39.73M | |
25.04M | $692.60M | |
947.94M | $185.19M | |
-15007658.00 | $223.97M | |
-10189682.00 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RVL Pharmaceuticals plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like RVL Pharmaceuticals plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is RVL Pharmaceuticals plc's Enterprise Value?
What is the highest Enterprise Value for RVL Pharmaceuticals plc (RVLP)?
What is the 3-year average Enterprise Value for RVL Pharmaceuticals plc (RVLP)?
What is the 5-year average Enterprise Value for RVL Pharmaceuticals plc (RVLP)?
How does the current Enterprise Value for RVL Pharmaceuticals plc (RVLP) compare to its historical average?